Autoimmunity: A Principal Pathological Mechanism Of COVD-19 Gene Therapy Harm And A Central Flaw In The LNP/MRNA Platform

 CoVax Disease encompasses multiple pathological mechanisms of which autoimmunity occupies a central position.

mRNA "Vaccines" are now associated with changeable disease manifestations that come from the widespread biodistribution of the mRNA gene therapy products that enter host cells and then transcribe mRNA code into Spike proteins that the host immune system does not recognize.

The authors even supply a mechanism whereby the gene therapy drugs activate Toll-like receptors that lead to the disease states called IMDs.

There was a 24-fold increase in reported cases of autoimmunity in VAERS going from only COVID-19 disease in 2020 to COVID-19 gene therapy injections and COVID-19 in 2021.

Autoimmunity most likely comes from foreign proteins translated from the injected synthetic mRNA. The inset diagram above illustrates how the mRNA component may cause autoimmune disease.

Incompletely tested, novel gene therapy is now associated with protean disease manifestations that derive from widespread biodistribution of products that enter host cells and transcribe mRNA code into Spike proteins that the host immune system has never seen.

The widespread organ involvement and severity of illness warrant consideration of a new class of illness, CoVax Disease, encompassing multiple pathological mechanisms of which autoimmunity occupies a central position.

https://dailyclout.io/report-70-part-4c-clinical-evidence-supporting-the-hypothesis-that-autoimmunity-is-one-of-the-principal-pathological-mechanisms-of-harm-from-covid-19-gene-therapy-drugs/